LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | CHIR-99021 | 0.0328 |
| Hs 578T | Nilotinib | 0.0332 |
| MDA-MB-231 | PD173074 | 0.0359 |
| MCF 10A | PD173074 | 0.0363 |
| MCF 10A | BMS345541 | 0.0397 |
| MCF7 | Enzastaurin | 0.0415 |
| MCF7 | SB590885 | 0.0427 |
| Hs 578T | GSK1904529A | 0.0468 |
| SK-BR-3 | CP466722 | 0.0472 |
| MCF 10A | Ruxolitinib | 0.0479 |
| Hs 578T | Lapatinib | 0.0496 |
| MCF 10A | SB590885 | 0.0517 |
| MCF 10A | CHIR-99021 | 0.0528 |
| Hs 578T | Linsitinib | 0.0529 |
| MCF 10A | XMD11-85h | 0.0541 |
| Hs 578T | Vemurafenib | 0.0546 |
| MCF 10A | Sorafenib | 0.0547 |
| SK-BR-3 | GSK1904529A | 0.0548 |
| Hs 578T | Linifanib | 0.0569 |
| Hs 578T | CP724714 | 0.0578 |
| Hs 578T | Seliciclib | 0.0580 |
| MCF 10A | Nilotinib | 0.0600 |
| MCF 10A | PHA-665752 | 0.0608 |
| SK-BR-3 | PHA-665752 | 0.0616 |
| SK-BR-3 | SU11274 | 0.0654 |